Glenview, Illinois Clinical Trials

A listing of Glenview, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 114 clinical trials
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

cardiovascular disease
overweight or obesity
body mass index
Novo Nordisk Investigational Site
 (4.5 away) Contact site
  • 7790 views
  • 25 Sep, 2021
  • +1166 other locations
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over express c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate efficacy in the selected population(s) (Stage …

growth factor
cancer chemotherapy
stage iv non-small cell lung cancer
cancer treatment
lung carcinoma
NorthShore University HealthSystem - Evanston /ID# 215583
 (6.7 away) Contact site
  • 119 views
  • 26 Sep, 2021
  • +380 other locations
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, …

tumour necrosis
tumor necrosis factor alpha
budesonide
tumor necrosis factor
adalimumab
Illinois Gastroenterology Group - Arlington Heights
 (8.5 away) Contact site
  • 63 views
  • 23 Sep, 2021
  • +175 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

oxaliplatin
leucovorin
hiv viral load
pulmonary disease
monoclonal antibodies
Hematology Oncology Associates of Illinois - Skokie
 (5.3 away) Contact site
  • 1047 views
  • 26 Sep, 2021
  • +595 other locations
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

tumor cells
ct scan
x-rays
intracranial meningioma
central pathology review
NorthShore University HealthSystem-Glenbrook Hospital
 (1.8 away) Contact site
  • 835 views
  • 22 Sep, 2021
  • +194 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

b-cell lymphoma
lymphoma
mantle cell lymphoma
marginal zone lymphoma
large b-cell lymphoma
TG Therapeutics Investigational Trial Site
 (3.1 away) Contact site
  • 12 views
  • 26 Sep, 2021
  • +203 other locations
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.

stenosis
ejection fraction
aortic valve replacement
transcatheter aortic valve implantation
NorthShore University HealthSystem Research Institution
 (6.7 away) Contact site
  • 464 views
  • 16 Sep, 2021
  • +86 other locations
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. There is an unmet medical need for effective treatment in pediatric patients and this study is being done to evaluate risankizumab in pediatric participants with moderate …

risankizumab
systemic therapy
plaque psoriasis
ustekinumab
inflammatory disease
Arlington Dermatology /ID# 217472
 (10.0 away) Contact site
  • 17 views
  • 23 Sep, 2021
  • +71 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab.

mini-mental state examination
florbetapir
positron emission tomography
flortaucipir
alzheimer's disease
Advocate Lutheran General Hospital
 (4.5 away) Contact site
  • 93 views
  • 26 Sep, 2021
  • +394 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

lebrikizumab
eczema
progestogen
topical agents
atopy
NorthShore University HealthSystem
 (4.5 away) Contact site
  • 154 views
  • 27 Sep, 2021
  • +357 other locations